Drug administration controller

ABSTRACT

A drug administration controller has a sensor that generates a sensor signal to a physiological measurement device, which measures a physiological parameter in response. A control output responsive to the physiological parameter or a metric derived from the physiological parameter causes a drug administration device to affect a treatment of a person, such as by initiating, pausing, halting or adjusting a dosage of drugs administered to the person.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a divisional of U.S. patent application Ser.No. 13/475,136, filed May 18, 2012, entitled Drug AdministrationController, which is a continuation of U.S. patent application Ser. No.11/654,904, filed Jan. 17, 2007, entitled Drug AdministrationController, which claims priority benefit under 35 U.S.C. § 119(e) toU.S. Provisional Patent Application Ser. No. 60/759,673, filed Jan. 17,2006, entitled Drug Administration Controller, and Ser. No. 60/764,946,filed Feb. 2, 2006, entitled Drug Administration Controller, all ofwhich are incorporated by reference herein in their entireties.

BACKGROUND

Physiological measurement systems employed in healthcare often featurevisual and audible alarm mechanisms that alert a caregiver when apatient's vital signs are outside of predetermined limits. For example,a pulse oximeter, which measures the oxygen saturation level of arterialblood, indicates oxygen supply. A typical pulse oximetry system has asensor that provides a signal output to a pulse oximeter monitor. Thesensor has an emitter configured with both red and infrared LEDs thatproject light through a fleshy medium to a detector so as to determinethe ratio of oxygenated and deoxygenated hemoglobin light absorption.The monitor has a signal processor, a display and an alarm. The signalprocessor inputs the conditioned and digitized sensor signal andcalculates oxygen saturation (SpO₂) along with pulse rate (PR), as iswell-known in the art. The display provides a numerical readout of apatient's oxygen saturation and pulse rate. The alarm provides anaudible indication when oxygen saturation or pulse rate are outside ofpredetermined limits.

Another pulse oximetry parameter is perfusion index (PI). PI is ameasure of perfusion at the pulse oximetry sensor site comparing thepulsatile (AC) signal to the non-pulsatile (DC) signal, expressed as apercentage ratio. An example is the PI Delta Alarm™ feature of theRadical 7™ Pulse CO-Oximeter™ available from Masimo Corporation, Irvine,Calif., which alerts clinicians to specified changes in PI. Inparticular, PI Delta indicates if PI at a monitored site decreases by aspecific level (delta) over a specified window of time, with bothvariables selectable by the user within predetermined ranges.

Tracking a series of desaturations over time is one metric that isderived from SpO₂ that is well-known in the art. See, e.g., Farney,Robert J., Jensen, Robert L.; Ear Oximetry to Detect Apnea andDifferentiate Rapid Eye Movement (REM) and Non-REM (NREM) Sleep:Screening for the Sleep Apnea Syndrome; Chest; April 1986; pages533-539, incorporated by reference herein. Traditional high and low SpO₂alarm limits alert clinicians to saturation levels that exceed userselected thresholds, and these thresholds are typically established at aconsiderable change from the patients' baseline saturation level.However, in select patient populations, substantial desaturation eventsthat exceed a typical low alarm limit threshold may be preceded by acycle of transient desaturations over a limited timeframe. The abilityto alert clinicians to a cycle of these smaller desaturations providesan earlier indication of a potential significant decline in thepatient's status and the need for more focused monitoring and/or achange in treatment. An example is the Desat Index Alarm™ feature of theRadical 7™, mentioned above, which enables clinicians to detect anincreasing quantity of smaller desaturations that may precede decliningrespiratory status. Desat Index is a measure responsive to patients thatexperience a specific number of desaturations beyond a defined levelfrom the patient's baseline saturation over a specific window of time,with each of these variables selectable by the user within predeterminedranges.

A physiological parameter that can be measured in addition to, or inlieu of, SpO₂ is respiration rate (RR). A respiration rate monitorutilizes a body sound sensor with piezoelectric membranes particularlysuited for the capture of acoustic waves and the conversion thereof intoelectric signals. To detect body sound, the piezoelectric membranes areused as mechano-electric transducers that are temporarily polarized whensubject to a physical force, such as when subjected to the mechanicalstress caused by the acoustic waves coming from the inside of apatient's body. The body sound sensor is typically attached to thesuprasternal notch or at the lateral neck near the pharynx so as todetect tracheal sounds. A sound sensor is described in U.S. Pat. No.6,661,161 entitled Piezoelectric Biological Sound Monitor With PrintedCircuit Board, incorporated by reference herein. A respiration ratemonitor is described in U.S. patent application Ser. No. 11/547,570entitled Non-Invasive Monitoring of Respiratory Rate, Heart Rate andApnea, incorporated by reference herein.

SUMMARY

Conventional patient monitors give insufficient advance warning ofdeteriorating patient health or the onset of a potentially seriousphysiological condition. Advantageously, a drug administrationcontroller is responsive to one or more physiological parameters inaddition to, or in lieu of, SpO₂ and PR, such as carboxyhemoglobin(HbCO), methemoglobin (HbMet), perfusion index (PI) and respiration rate(RR), to name a few. Further, a drug administration controller isadvantageously responsive not only to preset parameter limits but alsoto various metrics derived from measured physiological parameters, suchas trends, patterns and variability, alone or in combination, to name afew. As such, a drug administration controller is adapted to pausing orotherwise affecting drug administration based upon one or morephysiological parameters and one or more metrics. Parameter variabilityis described with respect to PI in U.S. patent application Ser. No.11/094,813 entitled Physiological Assessment System, incorporated byreference herein.

As an example, a drug administration controller may be responsive tochanges in HbMet. Gaseous nitric oxide (NO) is increasingly recognizedas an effective bacteriostatic or bacteriocidal agent. NO, however, cantoxically increase HbMet.

A drug administration controller may be responsive to changes inperfusion index, such as measured by PI Delta, described above. PI maychange dramatically in response to sympathetic changes invasoconstriction or vasodilation of peripheral vessels caused byanesthesia or pain. For example, painful stimulus causes a significantdecline of perfusion index.

As another example, a drug administration controller may be responsiveto a cycle of transient desaturations over a limited timeframe, such asindicated by Desat Index, described above. Patients receiving painmedication may be predisposed to respiratory depression. If the patienthas an underlying respiratory condition, pain medication may cause thepatient to spiral into a cascade of cyclic desaturations, whichinitially are mild but may worsen quickly, leading to respiratorydepression and even arrest.

As a further example, a drug administration controller may be responsiveto respiration rate (RR) monitoring, as described above. RR provides anaccurate marker for indicating acute respiratory dysfunction. Forexample, during conscious sedation, there is a risk of respiratorydepression, and changes in RR typically provide an earlier warning thandoes pulse oximetry alone.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a general block diagram of a drug administration controller;

FIGS. 2A-C are illustrations of drug infusion controller embodiments;

FIGS. 3A-C are illustrations of medical gas controller embodiments;

FIG. 4 is a general block diagram of a parameter processor embodiment;and

FIG. 5 is a detailed block diagram of a parameter processor embodiment.

DETAILED DESCRIPTION

FIG. 1 illustrates a drug administration controller 100 having one ormore sensors 106 generating sensor signals 107 in response tophysiological states of a living being, such as a patient 1. One or morephysiological measurement devices 108 generate physiological parametermeasurements 103 in response to the sensor Signals 107. A multipleparameter processor 101 processes the parameter measurements 103 aloneor in combination and generates monitor or control outputs 102, or both,in response. In an open-loop configuration, one or more monitor outputs102 are observed by a caregiver 2, who administers drugs or alters drugdoses in response. Alternatively, or in addition to, the caregiver 2initiates, pauses, halts or adjusts the settings of a drugadministration device 104. In a closed-loop configuration, a drugadministration device 104 is responsive to one or more control outputs102 so as to affect the treatment of the patient 1, includinginitiating, pausing, halting or adjusting the dosage of administereddrugs.

As shown in FIG. 1, the drug administration device may be, as examples,a drug infusion device or a medical gas inhalation device. Closed loopdrug infusion control is described in U.S. patent application Ser. No.11/075,389, entitled Physiological Parameter Controller, incorporated byreference herein. Closed loop respirator control is described in U.S.Pat. App. No. 60/729,470 entitled Multi-Channel Pulse OximetryVentilator Control, incorporated by reference herein.

Also shown in FIG. 1, sensors 106 may include an optical sensor attachedto a tissue site, such as a fingertip, for measuring one or more bloodparameters. Sensors 106 may also include blood pressure cuffs, ECG orEEG electrodes, CO₂ measuring capnography sensors and temperaturesensors to name but a few. Corresponding physiological measurementdevices 108 responsive to these sensors 106 may include blood parametermonitors, blood pressure monitors, capnometers, ECG and EEG monitors, asa few examples.

In one embodiment, sensors 106 include a pulse oximetry sensor, such asdescribed in U.S. Pat. No. 5,782,757 entitled Low Noise Optical Probesand physiological measurement devices 108 include a pulse oximeter, suchas described in U.S. Pat. No. 5,632,272 entitled Signal ProcessingApparatus, both assigned to Masimo Corporation, Irvine, Calif. and bothincorporated by reference herein. In another embodiment, sensors 106 andmeasurement devices 108 include a multiple wavelength sensor and acorresponding noninvasive blood parameter monitor, such as the RAD-57™and Radical-7™ for measuring SpO₂, CO, HbMet, pulse rate, perfusionindex and signal quality. The RAD-57 and Radical-7 are available fromMasimo Corporation, Irvine, Calif. In other embodiments, sensors 106also include any of LNOP® adhesive or reusable sensors, SofTouch™sensors, Hi-Fi Trauma™ or Blue™ sensor all available from MasimoCorporation, Irvine, Calif. Further, measurement devices 108 alsoinclude any of Radical®, SatShare™, Rad-9™, Rad-5™, Rad-5v™ or PPO+™Masimo SET® pulse oximeters all available from Masimo Corporation,Irvine, Calif.

In a particular embodiment, the control or monitor outputs 102 or bothare responsive to a Desat Index or a PI Delta or both, as describedabove. In another particular embodiment, one or more of the measurementdevices 108, the parameter processor 101 and the drug administrativedevice 104 are incorporated within a single unit. For example, thedevices may be incorporated within a single housing, or the devices maybe separately housed but physically and proximately connected.

Although sensors 106 are described above with respect to noninvasivetechnologies, sensors 106 may be invasive or noninvasive. Invasivemeasurements may require a person to prepare a blood or tissue sample,which is then processed by a physiological measurement device.

FIG. 2A illustrates a drug infusion controller embodiment 200 comprisinga drug-infusion pump 204, an optical sensor 206 attached to a patient 1and a noninvasive blood parameter monitor 208. The optical sensor 206provides a sensor Signal via a sensor cable 207 to the blood parametermonitor 208. The blood parameter monitor 208 generates blood parametermeasurements and processes those parameters to generate monitor andcontrol outputs 203 (FIG. 1), as described in further detail withrespect to FIGS. 4-5, below. In particular, the blood parameter monitor208 generates control signals via a control cable 202 to thedrug-infusion pump 204, and the drug-infusion pump 204 administers drugsto the patient 1 via an IV 209, accordingly.

In one embodiment, the administered drug is a nitrate, such as sodiumnitroprusside, and the blood parameter monitored is HbMet. In aparticular embodiment, the blood parameter monitor 208 provides acontrol output according to one or more entries in TABLE 1. In anotherparticular embodiment, the blood parameter monitor 208 provides acontrol output according to one or more entries in TABLE 2. In yetanother embodiment, a blood parameter monitor 208 confirms that themeasurement of HbMet is accurate, such as by checking a signal qualityparameter or by having multiple sensors 206 on the patient 1.

FIG. 2B illustrates another drug infusion controller embodiment 201comprising an optical sensor 206 and a combination blood-parametermonitor/drug infusion pump 205. In an embodiment, the drug infusioncontroller 200, 201 provides a visual display or audible alarmindicating various degrees of patient condition, such as green, yellowand red indicators or intermittent and low volume, medium volume andhigh volume tones.

TABLE 1 Rule Based Monitor Outputs RULE OUTPUT If HbMet > limitthreshold disable pump; trigger alarm if HbMet > trend threshold disablepump; trigger alarm

TABLE 2 Rule-Based Monitor Outputs RULE OUTPUT If HbMet > limitthreshold disable pump; trigger alarm if HbMet > trend threshold reducedosage; activate caution indicator

Another embodiment involves patient controlled analgesia (PCA), i.e. theadministered drug is an analgesia, and administration of the drug iscontrolled by the patient according to perceived pain levels. Analgesiaadministration, however, is paused in response to one or more bloodparameters and corresponding metrics. In one embodiment, the bloodparameter monitored is SpO₂ and the blood parameter monitor 208 providesa control output responsive to Desat Index. In a particular embodiment,PCA is paused or disabled according to TABLE 3.

TABLE 3 Rule Based PCA Control Outputs RULE OUTPUT If Desat Index >index limit pause PCA for predetermined period; activate alarm

In another embodiment, the blood parameter monitor 208 provides acontrol output responsive to a PI indication of pain. In this manner,the administration of anesthesia is controlled according to thepatient's perceived pain level. In a particular embodiment, PCA ispaused or enabled according to one or more entries of TABLE 4, where afalling PI results in a negative PI Delta relative to an establishedbaseline.

TABLE 4 Rule Based PCA Control Outputs RULE OUTPUT If PI Delta < deltalimit enable PCA; activate caution indicator If PI Delta < delta limitdisable PCA

FIG. 2C illustrates yet another drug infusion controller embodiment 211having a piezoelectric sensor 216 and a combinationblood-parameter/piezoelectric sound monitor/drug infusion pump 218. Apiezoelectric sensor 216 is attached to a patient's body 1 so as todetect tracheal sounds. The corresponding sensor signal is transmittedto the sound monitor 218 via a sensor cable 217. The sound monitor/pump218 generates biological sound measurements such as respiration rate(RR) and processes the measurements to generate control outputs. In aparticular embodiment, the monitor/pump 218 provides a control outputaccording to one or more entries of TABLE 5.

TABLE 5 Rule Based Monitor Outputs RULE OUTPUT If RR trend < trendthreshold reduce dosage; activate caution indicator If RR < limitthreshold disable pump; trigger alarm

FIG. 3A illustrates a medical gas controller embodiment 300 comprising aventilator 304 adapted to supply both oxygen and a medical gas, anoptical sensor 306 attached to a patient 1, and a noninvasive bloodparameter monitor 308. The optical sensor 306 provides a sensor signalvia a sensor cable 307 to the blood parameter monitor 308. The bloodparameter monitor 308 generates blood parameter measurements andprocesses those parameters to generate monitor and control outputs, asdescribed with respect to FIGS. 4-5, below. In particular, the bloodparameter monitor 308 generates control signals via a control cable 302to the ventilator 304, and the ventilator 304 administers a medical gasto the patient 1 via a breathing apparatus 309 accordingly. FIG. 3Billustrates another medical gas controller embodiment 301 comprising anoptical sensor 306 and a combination blood-parameter monitor/ventilator305.

In one embodiment, the administered medical gas is a NO, and the bloodparameter monitored is HbMet. In a particular embodiment, the bloodparameter monitor 308 provides a control output according to one or moreentries of TABLE 6. In another particular embodiment, the bloodparameter monitor 308 provides a control output according to one or moreentries of TABLE 7. In yet another embodiment, a blood parameter monitor308 confirms that the measurement of HbMet is accurate, such as bychecking a signal quality parameter or by having multiple sensors 306 onthe patient 1. In a further embodiment, the administered medical gas isCO, and the blood parameter monitored is HbCO.

TABLE 6 Rule Based Monitor Outputs RULE OUTPUT If HbMet trend > trendthreshold halt NO flow; trigger alarm If HbMet > limit threshold halt NOflow; trigger alarm

TABLE 7 Rule Based Monitor Outputs RULE OUTPUT If HbMet trend > trendthreshold reduce NO flow; activate caution indicator If HbMet > limitthreshold halt NO flow; trigger alarm

FIG. 3C illustrates yet another medical gas controller embodiment 311comprising a piezoelectric sound sensor 316 and a combination bloodparameter/piezoelectric sound monitor/ventilator 315. The sound sensor316 is attached to a patient's body 1 so as to detect tracheal soundsand provides a sensor signal via a sensor cable 317 to the sound monitor315. The sound monitor/ventilator 315 generates biological soundmeasurements such as respiration rate (RR) and provides control outputsresponsive to RR. In a particular embodiment, the monitor/ventilator 315provides a control output according to one or more entries of TABLE 8.

TABLE 8 Rule Based Monitor Outputs RULE OUTPUT If RR trend < trendthreshold reduce medical gas flow; activate caution indicator If RRlimit < limit threshold halt medical gas flow; trigger alarm

FIG. 4 illustrates a parameter processor 101, which may comprise anexpert system, a neural-network or a logic circuit as examples. Theparameter processor 101 has as inputs 103 one or more parameters fromone or more physiological measurement devices 108 (FIG. 1). Noninvasiveparameters may include oxygen saturation (SpO₂), pulse rate, perfusionindex, HbCO, HbMet and other Hb species, and data confidence indicators,such as derived from a pulse oximeter or a Pulse Co-Oximeter™ (MasimoCorporation) to name a few. Invasive parameters may include lactate,glucose or other blood constituent measurements. Capnography parametersmay include, for example, end tidal carbon dioxide (ETCO₂) andrespiration rate. Other measurement parameters that can be input to theparameter processor 101 may include ECG, EEG, blood pressure andtemperature to name a few. All of these parameters may indicatereal-time measurements or historical data, such as would indicate ameasurement trend. Pulse oximetry signal quality and data confidenceindicators are described in U.S. Pat. No. 6,684,090 entitled PulseOximetry Data Confidence Indicator, assigned to Masimo Corporation,Irvine, Calif. and incorporated by reference herein.

As shown in FIG. 4, monitor outputs 102 may be alarms. wellnessindicators, controls and diagnostics. Alarms may be used to alertmedical personnel to a potential urgent or emergency medical conditionin a patient under their care. Wellness indicators may be used to informmedical personnel as to patient condition stability or instability, suchas a less urgent but potentially deteriorating medical state orcondition. Controls may be used to affect the operation of a medicaltreatment device or other medical-related equipment. Diagnostics may bemessages or other indicators used to assist medical personnel indiagnosing or treating a patient condition.

User I/O 60, external devices 70 and wireless communication 80 alsointerface with the parameter processor 101 and provide communications tothe outside world. User I/O 60 allows manual data entry and control. Forexample, a menu-driven operator display may be provided to allow entryof predetermined alarm thresholds. External devices 70 may include PCsand network interfaces to name a few.

FIG. 5 illustrates one embodiment of a parameter processor 101 having apre-processor 510, a metric analyzer 520, a post-processor 530 and acontroller 540. The pre-processor 510 has inputs 103 that may bereal-time physiological parameter measurements, historical physiologicalparameter measurements, signal quality measures or any combination ofthe above. The pre-processor 510 generates metrics 512 that may includehistorical or real-time parameter trends, detected parameter patterns,parameter variability measures and signal quality indicators to name afew. As examples, trend metrics may indicate if a physiologicalparameter is increasing or decreasing at a certain rate over a certaintime, pattern metrics may indicate if a parameter oscillates within aparticular frequency range or over a particular time period, variabilitymetrics may indicate the extent of parameter stability.

As shown in FIG. 5, the metric analyzer 520 is configured to providetest results 522 to the post-processor based upon various rules appliedto the metrics 512 in view of various thresholds 524. As an example, themetric analyzer 520 may output an alarm trigger 522 to thepost-processor 530 when a parameter measurement 103 increases fasterthan a predetermined rate. This may be expressed by a rule that states“if trend metric exceeds trend threshold then trigger alarm.”

Also shown in FIG. 5, the post processor 530 inputs test results 522 andgenerates outputs 102 including alarms, wellness indictors, controls anddiagnostics. Alarms may be, for example, audible or visual alertswarning of critical conditions that need immediate attention. Wellnessindicators may be audible or visual cues, such as an intermittent,low-volume tone or a red/yellow/green light indicating a patient with astable or unstable physiological condition. Controls may be electricalor electronic, wired or wireless or mechanical outputs, to name a few,capable of interfacing with and affecting another device. As examples,controls 102 may interface with drug-infusion equipment or medical gasventilation equipment, as described with respect to FIGS. 2A-C and 3A-C,above.

Further shown in FIG. 5, the controller 540 interfaces with I/O 109, asdescribed with respect to FIG. 4, above. In one embodiment, the I/O 109provides predetermined thresholds, which the controller 540 transmits tothe metric analyzer 520. The controller 540 may also define metrics 514for the pre-processor 510 and define outputs 534 for the post-processor530.

A drug administration controller has been disclosed in detail inconnection with various embodiments. These embodiments are disclosed byway of examples only and are not to limit the scope of the claims thatfollow. One of ordinary skill in art will appreciate many variations andmodifications.

What is claimed is:
 1. A drug administration controller comprising: atleast one sensor that generates at least one sensor signal in responseto a physiological state of a living being that is being monitored; atleast one physiological measurement device that generates physiologicalparameter measurements of at least one physiological parameter inresponse to the at least one sensor signal; a processor that generatesone or more control outputs in response to the physiological parametermeasurements, wherein the physiological parameter measurements include ameasure of a number of times, which is greater than a predeterminedthreshold, that cyclical desaturations occur in the living being that isbeing monitored over a given timeframe; and a drug administration deviceresponsive to the one or more control outputs that are responsive to thephysiological parameter measurements including the measure of the numberof times, which is greater than a predetermined threshold, that cyclicaldesaturations occur in the living being that is being monitored over agiven timeframe so as to affect a treatment of the living being that isbeing monitored, including at least one of initiating, pausing, halting,or adjusting a dosage of drugs administered to the living being that isbeing monitored.
 2. The drug administration controller according toclaim 1, wherein the drug administration device includes at least oneof: a drug infusion device or a medical gas inhalation device.
 3. Thedrug administration controller according to claim 2, wherein the atleast one sensor comprises: an optical sensor attached to a tissue siteso as to measure at least one blood parameter; and a sound sensorattached proximate to a neck site so as to measure respiration rate.